Status:
COMPLETED
Correlation of Ultrasound and MRI Measurements of Quadratus Femoris Thickness and Ischiofemoral Distance in Clinically and Radiologically Diagnosed Ischiofemoral Impingement
Lead Sponsor:
Kutay Can ÇAMLICA
Conditions:
Hip Pain Chronic
Impingement Syndrome
Eligibility:
All Genders
18-65 years
Brief Summary
The goal of this observational study is to evaluate the correlation between ultrasound measurements of quadratus femoris muscle thickness and ischiofemoral distance, as well as clinical parameters, wi...
Detailed Description
Ischiofemoral impingement (IFI) was first described in 1977 by Karl A. Johnson, and his study is widely regarded as the first clinical definition of the syndrome. IFI is defined as an extra-articular ...
Eligibility Criteria
Inclusion
- Patients older than 18 years and younger than 65 years.
- Patients diagnosed by MRI
- Those with a body mass index below 25 kg/m2
- those with hip pain or positive physical examination tests
Exclusion
- Sciatic nerve damage detected on EMG
- Patients with operative ischiofemoral decompression
- Corticosteroid or any injection to the hip in the last 3 months
- History of peripheral nerve damage
- Femoroacetabular impingement
- Pregnancy
- Malignancy
- Inflammatory pathologies: rheumatic, septic
- Coxarthrosis-Kelgren-Lawrence grade 3-4
- Those who have undergone hip arthroplasty/surgery
- Causes of lumbar radiculopathy, spondylolisthesis
- Patients with increased femoral anteversion - patients with increased hip internal rotation (Toe-in)
Key Trial Info
Start Date :
October 10 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 10 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT07198646
Start Date
October 10 2024
End Date
April 10 2025
Last Update
September 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seyrantepe Hamidiye Etfal Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
Istanbul, sarıyer, Turkey (Türkiye)